HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element.

AbstractBACKGROUND & AIMS:
Caspase-8 is the apical caspase essential for triggering Fas-induced apoptosis. In this study, we investigated caspase-8 expression in hepatocellular carcinomas (HCCs) using recently described HCC mouse models (c-myc and IgEGF transgenes).
METHODS:
HCCs were isolated from c-myc and IgEGF transgenic animals. Expression of caspase-8 was monitored by reverse-transcription polymerase chain reaction. The murine caspase-8 promoter was characterized by luciferase-reporter analysis and the analysis of promoter methylation was performed by bisulfite genomic sequencing.
RESULTS:
In HCCs investigated, we frequently found a lack of caspase-8 messenger RNA expression. Genomic deletions at the caspase-8 locus did not contribute to caspase-8 silencing. We examined tumor-derived promoter sequences and found significant hypermethylation at distinct CpG sites. In parallel, we characterized the murine caspase-8 promoter and identified a 30-bp promoter element that is indispensable for basal promoter activity. This minimal promoter element contained SP1 binding motifs that are colocalized with CpG sites and were methylated in tumor-derived promoter sequences. Electrophoretic mobility shift assay analysis showed that methylation of these SP1 sites is sufficient to prevent SP1 complex formation. To support our data, we mimicked the methylation pattern of a tumor-derived caspase-8 promoter in vitro using CpG methylase and found a strong reduction of promoter activity.
CONCLUSIONS:
We show that HCCs are correlated frequently with silencing of caspase-8 expression and provide data suggesting that caspase-8 silencing is a direct consequence of inhibiting SP1-dependent transactivation caused by CpG methylation at its essential binding sites in the promoter region. Our data support the hypothesis that inhibition of apoptosis triggers hepatocarcinogenesis.
AuthorsChristian Liedtke, Nils-Holger Zschemisch, Anne Cohrs, Tania Roskams, Jürgen Borlak, Michael P Manns, Christian Trautwein
JournalGastroenterology (Gastroenterology) Vol. 129 Issue 5 Pg. 1602-15 (Nov 2005) ISSN: 0016-5085 [Print] United States
PMID16285959 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Sp1 Transcription Factor
  • Epidermal Growth Factor
  • Luciferases
  • CASP8 protein, human
  • Casp8 protein, mouse
  • Caspase 8
  • Caspases
Topics
  • Animals
  • Base Sequence
  • Carcinoma, Hepatocellular (genetics, metabolism)
  • Caspase 8
  • Caspases (genetics)
  • Cell Line, Tumor
  • Consensus Sequence
  • CpG Islands (physiology)
  • DNA Methylation
  • Epidermal Growth Factor (genetics)
  • Gene Silencing
  • Genes, Reporter
  • Genes, myc
  • Humans
  • Liver Neoplasms (genetics, metabolism)
  • Luciferases (genetics)
  • Mice
  • Mice, Transgenic
  • Molecular Sequence Data
  • Promoter Regions, Genetic (genetics)
  • Sp1 Transcription Factor (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: